Dr Annette Erhart,
Clinical Epidemiologist
MRC Unit The Gambia at LSHTM (The Gambia)

Molecular epidemiology of Group A Streptococcus in West Africa (acronym: MEGAS)

Read more

Dr Rowena Hoare,
Senior Research Fellow
Institute of Aquaculture, University of Stirling (UK)

Optimisation of novel mucosal vaccines to prevent bacterial diseases of Tilapia (Oreochromis niloticus)

Read more

Professor Calman MacLennan,
MRC Senior Clinical Fellow, Jenner Investigator and Group Leader,
Jenner Institute, University of Oxford (UK)

Advancing a native outer membrane vesicle vaccine against gonorrhoea towards clinical development

Read more

Dr Sudaxshina Murdan, Associate Professor
School of Pharmacy, University College London (UK)

Evaluation of the sublingual route of immunisation for the induction of mucosal and systemic immune responses to polysaccharide-protein conjugate vaccines 

Dr Andrew Preston, 
Reader in Microbial Pathogenesis
University of Bath (UK)

Developing whole cell vaccines with tailored immunogenicity through combinatorial engineering of lipid A

Dr Nadja Alexandra Vielot,
Postdoctoral Research Associate
Family Medicine, University of North Carolina at Chapel Hill (USA)

Prevalence and serotype distribution of group B Streptococcus in León, Nicaragua

Professor Brendan Wren,
Professor of Microbial Pathogenesis
London School of Hygiene and Tropical Medicine (UK)

Towards the production of Shigella plus” a low-cost recombinant Shigella glycoconjugate vaccines

 Dr Qibo Zhang, 
Senior Lecturer in ImmunologyInstitute of Infection and Global Health, University of Liverpool (UK)

Development of a novel intranasal vaccine against pneumococcal infection in children